| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 21 | 2021 | 253 | 6.080 |
Why?
|
| Embolization, Therapeutic | 26 | 2024 | 1392 | 3.850 |
Why?
|
| Pulmonary Veins | 8 | 2024 | 761 | 2.940 |
Why?
|
| Arteriovenous Malformations | 5 | 2024 | 396 | 2.550 |
Why?
|
| Angiography | 21 | 2023 | 1638 | 2.540 |
Why?
|
| Pulmonary Embolism | 16 | 2021 | 2375 | 2.240 |
Why?
|
| Radiography, Interventional | 20 | 2021 | 1095 | 2.190 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 8 | 2016 | 95 | 2.180 |
Why?
|
| Phlebography | 15 | 2017 | 333 | 2.030 |
Why?
|
| Liver Neoplasms | 21 | 2021 | 4251 | 2.000 |
Why?
|
| Chemoembolization, Therapeutic | 6 | 2017 | 131 | 1.990 |
Why?
|
| Venous Thrombosis | 13 | 2017 | 1240 | 1.900 |
Why?
|
| Radiology, Interventional | 13 | 2023 | 460 | 1.830 |
Why?
|
| Pulmonary Artery | 7 | 2024 | 1911 | 1.780 |
Why?
|
| Carcinoma, Hepatocellular | 10 | 2021 | 2217 | 1.670 |
Why?
|
| Diagnostic Imaging | 24 | 2023 | 3503 | 1.570 |
Why?
|
| Device Removal | 10 | 2023 | 655 | 1.530 |
Why?
|
| Hypertension, Portal | 6 | 2016 | 220 | 1.500 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 3 | 2024 | 139 | 1.490 |
Why?
|
| Vascular Diseases | 9 | 2023 | 1161 | 1.470 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 4 | 2023 | 197 | 1.280 |
Why?
|
| Yttrium Radioisotopes | 4 | 2021 | 93 | 1.280 |
Why?
|
| Vena Cava, Inferior | 9 | 2017 | 439 | 1.270 |
Why?
|
| Societies, Medical | 23 | 2023 | 3740 | 1.260 |
Why?
|
| Portal Vein | 5 | 2016 | 437 | 1.230 |
Why?
|
| Catheterization, Central Venous | 5 | 2014 | 514 | 1.230 |
Why?
|
| Varicose Veins | 4 | 2023 | 154 | 1.210 |
Why?
|
| Tomography, X-Ray Computed | 47 | 2023 | 20121 | 1.180 |
Why?
|
| Urinary Fistula | 2 | 2017 | 42 | 1.140 |
Why?
|
| Foreign-Body Migration | 3 | 2019 | 222 | 1.070 |
Why?
|
| Venous Thromboembolism | 8 | 2021 | 1670 | 1.070 |
Why?
|
| Iodine | 5 | 2023 | 286 | 1.060 |
Why?
|
| Endovascular Procedures | 11 | 2023 | 1980 | 1.060 |
Why?
|
| Aneurysm | 4 | 2011 | 339 | 1.050 |
Why?
|
| Aortic Aneurysm, Abdominal | 11 | 2019 | 1187 | 1.040 |
Why?
|
| Esophageal and Gastric Varices | 6 | 2023 | 207 | 1.030 |
Why?
|
| Graft Occlusion, Vascular | 5 | 2022 | 549 | 0.990 |
Why?
|
| Celiac Artery | 3 | 2010 | 69 | 0.960 |
Why?
|
| Contrast Media | 24 | 2023 | 5301 | 0.920 |
Why?
|
| Arteriovenous Shunt, Surgical | 4 | 2022 | 277 | 0.910 |
Why?
|
| Prosthesis Implantation | 4 | 2018 | 640 | 0.890 |
Why?
|
| Magnetic Resonance Angiography | 10 | 2019 | 1444 | 0.890 |
Why?
|
| Arteries | 5 | 2016 | 1119 | 0.860 |
Why?
|
| Peripheral Arterial Disease | 6 | 2023 | 1188 | 0.850 |
Why?
|
| Pancreas | 4 | 2011 | 1686 | 0.830 |
Why?
|
| Arterial Occlusive Diseases | 4 | 2018 | 793 | 0.810 |
Why?
|
| Nephrostomy, Percutaneous | 3 | 2017 | 85 | 0.810 |
Why?
|
| Treatment Outcome | 61 | 2024 | 63042 | 0.810 |
Why?
|
| Embolism, Paradoxical | 2 | 2012 | 58 | 0.810 |
Why?
|
| Iliac Artery | 3 | 2019 | 364 | 0.800 |
Why?
|
| Gastrointestinal Hemorrhage | 9 | 2023 | 1131 | 0.790 |
Why?
|
| Duodenum | 4 | 2010 | 484 | 0.780 |
Why?
|
| Viscera | 3 | 2011 | 139 | 0.780 |
Why?
|
| Leg | 3 | 2017 | 1116 | 0.770 |
Why?
|
| Microwaves | 3 | 2021 | 191 | 0.750 |
Why?
|
| Thrombolytic Therapy | 6 | 2016 | 2162 | 0.750 |
Why?
|
| Arteriovenous Fistula | 1 | 2024 | 315 | 0.740 |
Why?
|
| Renal Dialysis | 5 | 2022 | 1783 | 0.730 |
Why?
|
| Chylothorax | 2 | 2017 | 84 | 0.700 |
Why?
|
| Radiation Dosage | 10 | 2018 | 1928 | 0.690 |
Why?
|
| Radiology Department, Hospital | 2 | 2021 | 412 | 0.690 |
Why?
|
| Ultrasonography, Interventional | 4 | 2016 | 1486 | 0.690 |
Why?
|
| Catheterization, Peripheral | 6 | 2016 | 345 | 0.680 |
Why?
|
| Foramen Ovale, Patent | 2 | 2012 | 223 | 0.670 |
Why?
|
| Alloys | 1 | 2019 | 122 | 0.660 |
Why?
|
| Angiography, Digital Subtraction | 3 | 2017 | 341 | 0.660 |
Why?
|
| Wounds, Penetrating | 2 | 2012 | 307 | 0.660 |
Why?
|
| Angioplasty, Balloon | 3 | 2019 | 653 | 0.660 |
Why?
|
| Doxorubicin | 3 | 2017 | 2234 | 0.650 |
Why?
|
| Bronchial Arteries | 2 | 2009 | 20 | 0.650 |
Why?
|
| Polytetrafluoroethylene | 1 | 2019 | 233 | 0.640 |
Why?
|
| Cholecystectomy | 2 | 2021 | 395 | 0.620 |
Why?
|
| Humans | 186 | 2024 | 743811 | 0.620 |
Why?
|
| Blood Vessel Prosthesis Implantation | 6 | 2015 | 1391 | 0.620 |
Why?
|
| Respiratory Tract Fistula | 1 | 2017 | 26 | 0.610 |
Why?
|
| Stents | 10 | 2024 | 3280 | 0.590 |
Why?
|
| Evidence-Based Medicine | 21 | 2023 | 3608 | 0.590 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2019 | 318 | 0.590 |
Why?
|
| Pelvis | 2 | 2014 | 730 | 0.580 |
Why?
|
| Blood Viscosity | 1 | 2016 | 124 | 0.560 |
Why?
|
| Middle Aged | 79 | 2024 | 213241 | 0.560 |
Why?
|
| Hemorrhage | 6 | 2020 | 3458 | 0.560 |
Why?
|
| Surgical Instruments | 1 | 2019 | 395 | 0.550 |
Why?
|
| Retrospective Studies | 51 | 2024 | 77410 | 0.550 |
Why?
|
| Systemic Vasculitis | 1 | 2016 | 37 | 0.540 |
Why?
|
| Finger Injuries | 1 | 2017 | 139 | 0.530 |
Why?
|
| Blood Coagulation Tests | 1 | 2016 | 263 | 0.530 |
Why?
|
| Hypothermia | 1 | 2017 | 189 | 0.530 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2017 | 124 | 0.520 |
Why?
|
| Workflow | 1 | 2020 | 847 | 0.520 |
Why?
|
| Aorta, Abdominal | 4 | 2018 | 646 | 0.510 |
Why?
|
| Vascular Fistula | 1 | 2015 | 50 | 0.510 |
Why?
|
| Radiographic Image Enhancement | 5 | 2016 | 885 | 0.510 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2018 | 549 | 0.500 |
Why?
|
| Blood Coagulation | 2 | 2021 | 1127 | 0.500 |
Why?
|
| Salvage Therapy | 2 | 2021 | 1275 | 0.490 |
Why?
|
| Collateral Circulation | 1 | 2015 | 287 | 0.480 |
Why?
|
| Hepatic Encephalopathy | 1 | 2015 | 139 | 0.480 |
Why?
|
| Male Urogenital Diseases | 1 | 2014 | 48 | 0.480 |
Why?
|
| Radiology | 9 | 2021 | 2099 | 0.470 |
Why?
|
| Female | 94 | 2024 | 380020 | 0.470 |
Why?
|
| Patient Care Planning | 2 | 2018 | 915 | 0.470 |
Why?
|
| Hemoptysis | 3 | 2011 | 155 | 0.460 |
Why?
|
| Blood Coagulation Disorders | 1 | 2016 | 337 | 0.460 |
Why?
|
| Uterine Artery | 1 | 2013 | 36 | 0.460 |
Why?
|
| Multiple Organ Failure | 1 | 2016 | 389 | 0.450 |
Why?
|
| Ischemia | 5 | 2022 | 1907 | 0.450 |
Why?
|
| Quality Improvement | 11 | 2020 | 3750 | 0.450 |
Why?
|
| Urinoma | 1 | 2012 | 2 | 0.450 |
Why?
|
| Triage | 1 | 2020 | 977 | 0.450 |
Why?
|
| Connective Tissue Diseases | 1 | 2016 | 264 | 0.450 |
Why?
|
| Uterine Artery Embolization | 1 | 2013 | 62 | 0.440 |
Why?
|
| Azygos Vein | 1 | 2012 | 21 | 0.440 |
Why?
|
| Brachiocephalic Veins | 1 | 2012 | 23 | 0.430 |
Why?
|
| Male | 85 | 2023 | 349776 | 0.430 |
Why?
|
| Lower Extremity | 7 | 2023 | 1158 | 0.430 |
Why?
|
| Abdominal Wall | 1 | 2014 | 157 | 0.430 |
Why?
|
| Capsules | 1 | 2013 | 196 | 0.430 |
Why?
|
| Thrombosis | 3 | 2011 | 2968 | 0.430 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 660 | 0.420 |
Why?
|
| Iopamidol | 1 | 2012 | 191 | 0.420 |
Why?
|
| Embolism, Air | 1 | 2012 | 111 | 0.420 |
Why?
|
| Scimitar Syndrome | 1 | 2012 | 31 | 0.410 |
Why?
|
| Thromboembolism | 3 | 2011 | 987 | 0.410 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2014 | 500 | 0.410 |
Why?
|
| Aged | 58 | 2022 | 163178 | 0.410 |
Why?
|
| Renal Artery | 3 | 2011 | 399 | 0.410 |
Why?
|
| Aged, 80 and over | 34 | 2018 | 57744 | 0.410 |
Why?
|
| Upper Extremity Deep Vein Thrombosis | 3 | 2019 | 26 | 0.400 |
Why?
|
| Kidney Pelvis | 1 | 2012 | 188 | 0.400 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2012 | 153 | 0.400 |
Why?
|
| Prosthesis Design | 9 | 2018 | 2103 | 0.390 |
Why?
|
| Constriction, Pathologic | 6 | 2022 | 1108 | 0.390 |
Why?
|
| Intracranial Embolism | 1 | 2012 | 202 | 0.380 |
Why?
|
| Diagnosis, Differential | 17 | 2021 | 12954 | 0.380 |
Why?
|
| Postoperative Complications | 7 | 2018 | 15281 | 0.380 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2015 | 1263 | 0.380 |
Why?
|
| Aorta | 1 | 2018 | 2062 | 0.370 |
Why?
|
| Leiomyoma | 2 | 2013 | 730 | 0.370 |
Why?
|
| Catheter Ablation | 3 | 2021 | 2758 | 0.370 |
Why?
|
| Fluoroscopy | 5 | 2016 | 924 | 0.360 |
Why?
|
| Adult | 51 | 2024 | 213889 | 0.360 |
Why?
|
| Radiopharmaceuticals | 4 | 2017 | 2647 | 0.350 |
Why?
|
| Anticoagulants | 8 | 2019 | 4599 | 0.350 |
Why?
|
| Amenorrhea | 1 | 2013 | 485 | 0.350 |
Why?
|
| Vasa Vasorum | 1 | 2009 | 26 | 0.350 |
Why?
|
| Catheters, Indwelling | 1 | 2012 | 427 | 0.340 |
Why?
|
| Infarction | 1 | 2010 | 244 | 0.330 |
Why?
|
| Decompression, Surgical | 1 | 2014 | 594 | 0.330 |
Why?
|
| Time Factors | 17 | 2022 | 40038 | 0.330 |
Why?
|
| Drug Carriers | 1 | 2013 | 690 | 0.320 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 1534 | 0.320 |
Why?
|
| Uterine Neoplasms | 3 | 2013 | 1513 | 0.320 |
Why?
|
| Aneurysm, Ruptured | 3 | 2014 | 452 | 0.310 |
Why?
|
| Aneurysm, False | 1 | 2011 | 276 | 0.310 |
Why?
|
| Abdomen | 1 | 2014 | 1117 | 0.310 |
Why?
|
| Aortic Diseases | 4 | 2021 | 743 | 0.310 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2009 | 214 | 0.300 |
Why?
|
| Leg Injuries | 1 | 2009 | 178 | 0.300 |
Why?
|
| Hemodynamics | 3 | 2018 | 4197 | 0.300 |
Why?
|
| Brachytherapy | 1 | 2015 | 1247 | 0.300 |
Why?
|
| Liver Transplantation | 4 | 2023 | 2119 | 0.290 |
Why?
|
| Cerebral Angiography | 1 | 2012 | 1285 | 0.290 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 11036 | 0.290 |
Why?
|
| Incidental Findings | 1 | 2012 | 689 | 0.290 |
Why?
|
| Vascular Surgical Procedures | 4 | 2016 | 1476 | 0.280 |
Why?
|
| Prosthesis-Related Infections | 1 | 2012 | 537 | 0.280 |
Why?
|
| Equipment Design | 6 | 2019 | 3574 | 0.280 |
Why?
|
| Catheters | 2 | 2023 | 424 | 0.280 |
Why?
|
| Thoracic Outlet Syndrome | 2 | 2020 | 85 | 0.280 |
Why?
|
| Risk Factors | 22 | 2023 | 72252 | 0.280 |
Why?
|
| Palpation | 3 | 2017 | 167 | 0.280 |
Why?
|
| Radioisotopes | 1 | 2008 | 500 | 0.280 |
Why?
|
| Vasculitis | 2 | 2021 | 519 | 0.280 |
Why?
|
| Predictive Value of Tests | 10 | 2016 | 15067 | 0.270 |
Why?
|
| Lung Transplantation | 1 | 2015 | 1155 | 0.270 |
Why?
|
| Pulmonary Circulation | 2 | 2019 | 739 | 0.270 |
Why?
|
| Aortic Rupture | 1 | 2009 | 312 | 0.270 |
Why?
|
| Practice Guidelines as Topic | 8 | 2019 | 7270 | 0.270 |
Why?
|
| Pancreatitis | 2 | 2011 | 1092 | 0.270 |
Why?
|
| Acute Disease | 7 | 2017 | 7150 | 0.270 |
Why?
|
| Neurofibromatosis 1 | 1 | 2011 | 570 | 0.270 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2018 | 8939 | 0.260 |
Why?
|
| Vascular Patency | 5 | 2022 | 887 | 0.260 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3134 | 0.260 |
Why?
|
| Image Enhancement | 2 | 2014 | 2915 | 0.260 |
Why?
|
| Cesarean Section | 1 | 2014 | 1365 | 0.260 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3241 | 0.260 |
Why?
|
| United States | 26 | 2023 | 69859 | 0.250 |
Why?
|
| Mesenteric Artery, Superior | 3 | 2010 | 101 | 0.240 |
Why?
|
| Quality Indicators, Health Care | 4 | 2016 | 1831 | 0.240 |
Why?
|
| Hematoma | 1 | 2009 | 758 | 0.240 |
Why?
|
| Portography | 2 | 2016 | 12 | 0.230 |
Why?
|
| Diabetes Complications | 1 | 2011 | 1360 | 0.230 |
Why?
|
| Ultrasonography | 7 | 2023 | 5986 | 0.230 |
Why?
|
| Cerebrovascular Disorders | 1 | 2010 | 1504 | 0.230 |
Why?
|
| Polyurethanes | 1 | 2024 | 107 | 0.230 |
Why?
|
| Dilatation, Pathologic | 2 | 2017 | 520 | 0.220 |
Why?
|
| Survival Rate | 7 | 2018 | 12786 | 0.220 |
Why?
|
| Balloon Occlusion | 1 | 2023 | 126 | 0.210 |
Why?
|
| Kidney | 3 | 2010 | 7185 | 0.210 |
Why?
|
| Prosthesis Failure | 4 | 2016 | 1203 | 0.210 |
Why?
|
| Heart Valve Diseases | 1 | 2010 | 1073 | 0.210 |
Why?
|
| Mesenteric Vascular Occlusion | 2 | 2016 | 97 | 0.210 |
Why?
|
| Young Adult | 15 | 2019 | 56392 | 0.210 |
Why?
|
| Thoracic Injuries | 2 | 2017 | 272 | 0.210 |
Why?
|
| Mitral Valve | 1 | 2010 | 1491 | 0.200 |
Why?
|
| Calcinosis | 1 | 2010 | 1495 | 0.200 |
Why?
|
| Ureterocele | 1 | 2001 | 28 | 0.200 |
Why?
|
| Colorectal Neoplasms | 2 | 2021 | 6773 | 0.200 |
Why?
|
| Wolffian Ducts | 1 | 2001 | 23 | 0.200 |
Why?
|
| Peer Review | 1 | 2023 | 209 | 0.190 |
Why?
|
| Risk Assessment | 10 | 2023 | 23327 | 0.190 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2023 | 162 | 0.190 |
Why?
|
| Treatment Failure | 2 | 2020 | 2617 | 0.190 |
Why?
|
| Boston | 6 | 2014 | 9310 | 0.190 |
Why?
|
| Aortography | 4 | 2016 | 437 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2021 | 35409 | 0.190 |
Why?
|
| Intermittent Claudication | 1 | 2022 | 309 | 0.180 |
Why?
|
| Pulmonary Infarction | 1 | 2019 | 9 | 0.180 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2020 | 795 | 0.180 |
Why?
|
| Adenocarcinoma | 5 | 2014 | 6363 | 0.180 |
Why?
|
| Kidney Diseases | 1 | 2011 | 2146 | 0.180 |
Why?
|
| Radiology Information Systems | 2 | 2023 | 523 | 0.180 |
Why?
|
| Punctures | 3 | 2016 | 374 | 0.180 |
Why?
|
| Lymphography | 2 | 2017 | 201 | 0.170 |
Why?
|
| Recurrence | 6 | 2018 | 8337 | 0.170 |
Why?
|
| Preoperative Care | 5 | 2018 | 2251 | 0.170 |
Why?
|
| Thrombectomy | 3 | 2014 | 680 | 0.170 |
Why?
|
| Indans | 1 | 2019 | 96 | 0.170 |
Why?
|
| Portal Pressure | 2 | 2016 | 62 | 0.170 |
Why?
|
| Aorta, Thoracic | 3 | 2012 | 1084 | 0.170 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2018 | 23 | 0.170 |
Why?
|
| Abdominal Injuries | 1 | 2022 | 352 | 0.170 |
Why?
|
| Quality Control | 2 | 2019 | 841 | 0.160 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2020 | 172 | 0.160 |
Why?
|
| Positron-Emission Tomography | 4 | 2017 | 6237 | 0.160 |
Why?
|
| Rectal Neoplasms | 5 | 2005 | 1205 | 0.160 |
Why?
|
| Equipment Failure Analysis | 3 | 2009 | 864 | 0.160 |
Why?
|
| Acute Kidney Injury | 2 | 2023 | 1968 | 0.160 |
Why?
|
| Prevalence | 5 | 2013 | 15211 | 0.160 |
Why?
|
| Radiography | 5 | 2021 | 7010 | 0.160 |
Why?
|
| Wound Healing | 1 | 2009 | 2776 | 0.150 |
Why?
|
| Venous Insufficiency | 2 | 2009 | 103 | 0.150 |
Why?
|
| Dilatation | 1 | 2019 | 291 | 0.150 |
Why?
|
| Pelvic Bones | 1 | 2019 | 265 | 0.150 |
Why?
|
| Sensitivity and Specificity | 11 | 2019 | 14714 | 0.150 |
Why?
|
| Consensus | 5 | 2021 | 2954 | 0.150 |
Why?
|
| Liver Diseases | 2 | 2017 | 1253 | 0.150 |
Why?
|
| Radiation Protection | 3 | 2016 | 419 | 0.150 |
Why?
|
| Intestinal Diseases | 1 | 2022 | 531 | 0.150 |
Why?
|
| Sulfones | 1 | 2019 | 434 | 0.150 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2005 | 991 | 0.150 |
Why?
|
| Thoracic Duct | 1 | 2017 | 63 | 0.140 |
Why?
|
| Ultrasonography, Doppler | 2 | 2016 | 458 | 0.140 |
Why?
|
| Popliteal Vein | 2 | 2013 | 43 | 0.140 |
Why?
|
| Academic Medical Centers | 2 | 2020 | 2760 | 0.140 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2017 | 141 | 0.140 |
Why?
|
| Catheterization | 2 | 2013 | 1469 | 0.130 |
Why?
|
| Antineoplastic Agents | 5 | 2014 | 13691 | 0.130 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2012 | 1184 | 0.130 |
Why?
|
| Nephrotic Syndrome | 1 | 2019 | 389 | 0.130 |
Why?
|
| Lactulose | 1 | 2015 | 33 | 0.130 |
Why?
|
| Adolescent | 13 | 2022 | 85729 | 0.130 |
Why?
|
| Texas | 1 | 2016 | 390 | 0.130 |
Why?
|
| Cysts | 1 | 2001 | 678 | 0.130 |
Why?
|
| Amines | 1 | 2017 | 276 | 0.130 |
Why?
|
| Angioplasty | 1 | 2018 | 364 | 0.130 |
Why?
|
| Liver Function Tests | 1 | 2016 | 529 | 0.130 |
Why?
|
| Survival Analysis | 3 | 2013 | 10251 | 0.130 |
Why?
|
| Hepatic Veins | 1 | 2015 | 112 | 0.130 |
Why?
|
| Hepatectomy | 2 | 2021 | 550 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 3 | 2009 | 9272 | 0.120 |
Why?
|
| Jejunostomy | 1 | 2014 | 57 | 0.120 |
Why?
|
| Elasticity | 1 | 2016 | 657 | 0.120 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 6895 | 0.120 |
Why?
|
| Biliary Tract Diseases | 1 | 2015 | 161 | 0.120 |
Why?
|
| Heart Failure | 1 | 2018 | 10896 | 0.120 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 2015 | 504 | 0.120 |
Why?
|
| Extremities | 1 | 2019 | 867 | 0.120 |
Why?
|
| Cohort Studies | 6 | 2021 | 40545 | 0.120 |
Why?
|
| Chronic Disease | 5 | 2023 | 9139 | 0.120 |
Why?
|
| Vascular Malformations | 1 | 2019 | 454 | 0.120 |
Why?
|
| Reproducibility of Results | 7 | 2016 | 19894 | 0.120 |
Why?
|
| Prognosis | 7 | 2018 | 29052 | 0.120 |
Why?
|
| Lidocaine | 1 | 2017 | 544 | 0.120 |
Why?
|
| Insurance Claim Review | 1 | 2018 | 719 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1114 | 0.120 |
Why?
|
| Practice Management, Medical | 1 | 2015 | 196 | 0.110 |
Why?
|
| Upper Extremity | 2 | 2016 | 647 | 0.110 |
Why?
|
| Infection Control | 1 | 2021 | 964 | 0.110 |
Why?
|
| Urologic Diseases | 1 | 2016 | 243 | 0.110 |
Why?
|
| Needles | 1 | 2016 | 449 | 0.110 |
Why?
|
| Perioperative Nursing | 1 | 2012 | 18 | 0.110 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 12243 | 0.110 |
Why?
|
| Feasibility Studies | 3 | 2018 | 5078 | 0.110 |
Why?
|
| Hemostatic Techniques | 1 | 2013 | 116 | 0.110 |
Why?
|
| Therapeutics | 1 | 2013 | 116 | 0.110 |
Why?
|
| Hygiene | 1 | 2012 | 97 | 0.110 |
Why?
|
| Comorbidity | 3 | 2013 | 10380 | 0.110 |
Why?
|
| Injections, Intra-Arterial | 2 | 2013 | 193 | 0.110 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2015 | 933 | 0.110 |
Why?
|
| Vascular System Injuries | 1 | 2016 | 250 | 0.110 |
Why?
|
| Neoplasms | 4 | 2019 | 21675 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 5752 | 0.100 |
Why?
|
| Abdominal Cavity | 1 | 2012 | 52 | 0.100 |
Why?
|
| Nephrology | 1 | 2016 | 263 | 0.100 |
Why?
|
| Gastrostomy | 1 | 2014 | 310 | 0.100 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2013 | 295 | 0.100 |
Why?
|
| Follow-Up Studies | 8 | 2023 | 39001 | 0.100 |
Why?
|
| Sterilization | 1 | 2012 | 133 | 0.100 |
Why?
|
| Quality Assurance, Health Care | 2 | 2015 | 2211 | 0.100 |
Why?
|
| Living Donors | 2 | 2007 | 621 | 0.100 |
Why?
|
| Algorithms | 3 | 2023 | 13869 | 0.100 |
Why?
|
| Incidence | 4 | 2012 | 20948 | 0.100 |
Why?
|
| Dyspnea | 1 | 2019 | 1303 | 0.100 |
Why?
|
| Stroke | 2 | 2011 | 9975 | 0.100 |
Why?
|
| Hydronephrosis | 1 | 2012 | 269 | 0.100 |
Why?
|
| Massachusetts | 3 | 2020 | 8660 | 0.100 |
Why?
|
| Rupture | 1 | 2012 | 433 | 0.100 |
Why?
|
| Equipment Failure | 2 | 2014 | 578 | 0.100 |
Why?
|
| Pulsatile Flow | 1 | 2012 | 332 | 0.100 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2014 | 732 | 0.100 |
Why?
|
| Combined Modality Therapy | 4 | 2019 | 8637 | 0.100 |
Why?
|
| Polyvinyl Alcohol | 1 | 2011 | 74 | 0.100 |
Why?
|
| Regional Blood Flow | 2 | 2012 | 1525 | 0.100 |
Why?
|
| Biopsy | 2 | 2020 | 6750 | 0.100 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2017 | 1118 | 0.090 |
Why?
|
| Acrylic Resins | 1 | 2011 | 139 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1186 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2021 | 6539 | 0.090 |
Why?
|
| Patient Care Team | 2 | 2020 | 2528 | 0.090 |
Why?
|
| Radiography, Thoracic | 1 | 2017 | 1265 | 0.090 |
Why?
|
| Abdominal Pain | 2 | 2014 | 1064 | 0.090 |
Why?
|
| Drainage | 3 | 2023 | 1142 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 1422 | 0.090 |
Why?
|
| Fetal Macrosomia | 1 | 2011 | 124 | 0.090 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2019 | 3142 | 0.090 |
Why?
|
| Anesthetics, Local | 1 | 2017 | 985 | 0.090 |
Why?
|
| Fusobacterium Infections | 1 | 2010 | 53 | 0.090 |
Why?
|
| Analgesics | 1 | 2017 | 1040 | 0.090 |
Why?
|
| Plethysmography | 1 | 2010 | 180 | 0.090 |
Why?
|
| Disease Progression | 2 | 2020 | 13273 | 0.090 |
Why?
|
| Venous Pressure | 1 | 2009 | 56 | 0.090 |
Why?
|
| Pregnancy in Diabetics | 1 | 2011 | 179 | 0.090 |
Why?
|
| Fluorocarbon Polymers | 1 | 2008 | 16 | 0.090 |
Why?
|
| Gelatin | 1 | 2011 | 226 | 0.090 |
Why?
|
| Brain Abscess | 1 | 2010 | 119 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2019 | 2922 | 0.080 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 690 | 0.080 |
Why?
|
| Jejunal Diseases | 1 | 2009 | 50 | 0.080 |
Why?
|
| Ovary | 1 | 2013 | 980 | 0.080 |
Why?
|
| Blood Pressure Determination | 1 | 2012 | 633 | 0.080 |
Why?
|
| Thrombophilia | 1 | 2011 | 305 | 0.080 |
Why?
|
| Time | 1 | 2010 | 542 | 0.080 |
Why?
|
| Kidney Neoplasms | 2 | 2019 | 4260 | 0.080 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 1423 | 0.080 |
Why?
|
| Patient Readmission | 1 | 2022 | 3117 | 0.080 |
Why?
|
| Pyridoxal Phosphate | 2 | 2005 | 127 | 0.080 |
Why?
|
| Hemostatics | 1 | 2011 | 229 | 0.080 |
Why?
|
| Edetic Acid | 2 | 2005 | 274 | 0.080 |
Why?
|
| Microspheres | 1 | 2011 | 777 | 0.080 |
Why?
|
| Hypertension, Renovascular | 1 | 2008 | 123 | 0.080 |
Why?
|
| Bile Duct Neoplasms | 1 | 2013 | 567 | 0.080 |
Why?
|
| Diverticulum | 1 | 2009 | 134 | 0.080 |
Why?
|
| Cholangiocarcinoma | 1 | 2013 | 516 | 0.080 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2008 | 40 | 0.080 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2010 | 426 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2019 | 1946 | 0.080 |
Why?
|
| Swine | 4 | 2023 | 5909 | 0.080 |
Why?
|
| Fibrosis | 1 | 2014 | 2030 | 0.080 |
Why?
|
| Abdomen, Acute | 1 | 2008 | 123 | 0.070 |
Why?
|
| Pacemaker, Artificial | 1 | 2013 | 815 | 0.070 |
Why?
|
| Liver | 2 | 2017 | 7479 | 0.070 |
Why?
|
| Bronchoscopy | 2 | 2011 | 861 | 0.070 |
Why?
|
| Delphi Technique | 3 | 2016 | 777 | 0.070 |
Why?
|
| Research Design | 1 | 2023 | 5983 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2013 | 6356 | 0.070 |
Why?
|
| Echocardiography, Doppler | 1 | 2011 | 935 | 0.070 |
Why?
|
| Diabetic Foot | 1 | 2011 | 355 | 0.070 |
Why?
|
| Gallbladder Diseases | 1 | 2008 | 125 | 0.070 |
Why?
|
| Jejunum | 1 | 2009 | 480 | 0.070 |
Why?
|
| Pregnancy | 4 | 2014 | 29140 | 0.070 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2011 | 370 | 0.070 |
Why?
|
| Coronary Angiography | 2 | 2009 | 4576 | 0.070 |
Why?
|
| Saphenous Vein | 1 | 2010 | 532 | 0.070 |
Why?
|
| Causality | 1 | 2013 | 1275 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6487 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2009 | 2037 | 0.070 |
Why?
|
| Gallbladder | 1 | 2008 | 302 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 1859 | 0.070 |
Why?
|
| User-Computer Interface | 2 | 2016 | 1431 | 0.070 |
Why?
|
| Shock, Hemorrhagic | 1 | 2008 | 220 | 0.070 |
Why?
|
| Operating Rooms | 1 | 2012 | 817 | 0.070 |
Why?
|
| Gastric Bypass | 1 | 2014 | 812 | 0.070 |
Why?
|
| Patient Selection | 2 | 2016 | 4210 | 0.070 |
Why?
|
| Pandemics | 3 | 2021 | 8385 | 0.070 |
Why?
|
| Streptococcal Infections | 1 | 2010 | 636 | 0.070 |
Why?
|
| Bronchiectasis | 1 | 2006 | 128 | 0.070 |
Why?
|
| Diabetic Angiopathies | 1 | 2011 | 819 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2011 | 2298 | 0.070 |
Why?
|
| Mediastinum | 1 | 2006 | 267 | 0.060 |
Why?
|
| Shock | 1 | 2008 | 318 | 0.060 |
Why?
|
| Veins | 1 | 2009 | 770 | 0.060 |
Why?
|
| Vascular Neoplasms | 1 | 2007 | 175 | 0.060 |
Why?
|
| Mesentery | 1 | 2005 | 205 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 3617 | 0.060 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2009 | 455 | 0.060 |
Why?
|
| Fatty Liver | 1 | 2011 | 728 | 0.060 |
Why?
|
| Stomach Neoplasms | 1 | 2014 | 1332 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2018 | 5316 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2010 | 970 | 0.060 |
Why?
|
| Radiation Injuries | 1 | 2012 | 1180 | 0.060 |
Why?
|
| Giant Cell Arteritis | 1 | 2008 | 292 | 0.060 |
Why?
|
| Clinical Competence | 2 | 2020 | 4687 | 0.060 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2009 | 740 | 0.060 |
Why?
|
| Gyrus Cinguli | 1 | 2010 | 1091 | 0.060 |
Why?
|
| Probability | 1 | 2009 | 2505 | 0.060 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2004 | 156 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2014 | 15526 | 0.060 |
Why?
|
| Diabetic Nephropathies | 1 | 2011 | 984 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2008 | 1092 | 0.060 |
Why?
|
| Pregnancy Outcome | 1 | 2014 | 2794 | 0.060 |
Why?
|
| Defibrillators, Implantable | 1 | 2013 | 1439 | 0.060 |
Why?
|
| Aortic Aneurysm | 1 | 2008 | 644 | 0.060 |
Why?
|
| Logistic Models | 1 | 2018 | 13404 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2023 | 5787 | 0.050 |
Why?
|
| Electric Power Supplies | 1 | 2023 | 98 | 0.050 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 1537 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2008 | 1851 | 0.050 |
Why?
|
| Laser Therapy | 1 | 2010 | 1071 | 0.050 |
Why?
|
| Colonic Neoplasms | 2 | 2005 | 2542 | 0.050 |
Why?
|
| Tomography, Spiral Computed | 1 | 2004 | 280 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2013 | 2265 | 0.050 |
Why?
|
| Leiomyosarcoma | 1 | 2007 | 477 | 0.050 |
Why?
|
| Electronics | 1 | 2023 | 321 | 0.050 |
Why?
|
| Pain | 1 | 2017 | 4987 | 0.050 |
Why?
|
| Program Development | 2 | 2020 | 1314 | 0.050 |
Why?
|
| Hypotension | 1 | 2008 | 884 | 0.050 |
Why?
|
| Endometrial Neoplasms | 1 | 2011 | 1350 | 0.050 |
Why?
|
| Fibrinolytic Agents | 1 | 2011 | 2159 | 0.050 |
Why?
|
| Aortic Valve Stenosis | 1 | 2013 | 1955 | 0.050 |
Why?
|
| Gadolinium | 1 | 2006 | 950 | 0.050 |
Why?
|
| Carotid Stenosis | 1 | 2008 | 854 | 0.050 |
Why?
|
| Portal System | 1 | 2020 | 52 | 0.050 |
Why?
|
| Kidney Transplantation | 2 | 2007 | 4251 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 2534 | 0.050 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2007 | 933 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 2023 | 607 | 0.040 |
Why?
|
| Urography | 1 | 2001 | 313 | 0.040 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2005 | 2016 | 0.040 |
Why?
|
| Limb Salvage | 1 | 2022 | 433 | 0.040 |
Why?
|
| Pediatrics | 1 | 2014 | 3474 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2012 | 2407 | 0.040 |
Why?
|
| Pericardium | 1 | 2023 | 667 | 0.040 |
Why?
|
| Neoplasms, Second Primary | 1 | 2007 | 1063 | 0.040 |
Why?
|
| Age Factors | 2 | 2015 | 18355 | 0.040 |
Why?
|
| Organizational Objectives | 1 | 2020 | 438 | 0.040 |
Why?
|
| Palliative Care | 1 | 2013 | 3490 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2019 | 323 | 0.040 |
Why?
|
| Endoleak | 1 | 2018 | 106 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2006 | 2479 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 2006 | 1178 | 0.040 |
Why?
|
| Necrosis | 1 | 2022 | 1642 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 2012 | 2861 | 0.040 |
Why?
|
| Nerve Regeneration | 1 | 2023 | 788 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 7784 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2023 | 1133 | 0.040 |
Why?
|
| Alcoholism | 1 | 2008 | 1907 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2004 | 1404 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2008 | 1917 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2019 | 53250 | 0.040 |
Why?
|
| Retreatment | 1 | 2018 | 609 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2009 | 8316 | 0.030 |
Why?
|
| Critical Care | 1 | 2008 | 2647 | 0.030 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 695 | 0.030 |
Why?
|
| Internationality | 2 | 2012 | 1002 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 2638 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2016 | 10940 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 4839 | 0.030 |
Why?
|
| Acute Coronary Syndrome | 1 | 2008 | 2337 | 0.030 |
Why?
|
| Safety Management | 1 | 2020 | 782 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2020 | 1146 | 0.030 |
Why?
|
| Learning | 1 | 2023 | 1710 | 0.030 |
Why?
|
| Reoperation | 2 | 2015 | 4200 | 0.030 |
Why?
|
| Reaction Time | 1 | 2020 | 2091 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2006 | 4033 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 7658 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2004 | 2134 | 0.030 |
Why?
|
| Rectum | 2 | 2009 | 904 | 0.030 |
Why?
|
| Organizational Innovation | 1 | 2015 | 559 | 0.030 |
Why?
|
| Artifacts | 2 | 2012 | 1904 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2007 | 9239 | 0.020 |
Why?
|
| Echocardiography | 1 | 2023 | 5096 | 0.020 |
Why?
|
| Critical Pathways | 1 | 2015 | 476 | 0.020 |
Why?
|
| Endoscopy | 1 | 2020 | 1781 | 0.020 |
Why?
|
| Streptococcus anginosus | 1 | 2010 | 24 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2015 | 40964 | 0.020 |
Why?
|
| Endosonography | 2 | 2004 | 610 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 2020 | 1787 | 0.020 |
Why?
|
| Lung | 1 | 2008 | 9858 | 0.020 |
Why?
|
| Epistaxis | 1 | 2010 | 111 | 0.020 |
Why?
|
| Fusobacterium nucleatum | 1 | 2010 | 163 | 0.020 |
Why?
|
| Obesity | 1 | 2011 | 12744 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2008 | 6485 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2005 | 5264 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 814 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2010 | 413 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2015 | 2483 | 0.020 |
Why?
|
| Inpatients | 1 | 2018 | 2515 | 0.020 |
Why?
|
| Iliac Vein | 1 | 2007 | 72 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 1956 | 0.020 |
Why?
|
| Animals | 4 | 2023 | 168660 | 0.020 |
Why?
|
| Cardiology | 1 | 2016 | 1668 | 0.020 |
Why?
|
| Renal Veins | 1 | 2005 | 108 | 0.020 |
Why?
|
| Respiratory Mechanics | 1 | 2009 | 686 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 11524 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5170 | 0.020 |
Why?
|
| Cholangiography | 1 | 2004 | 189 | 0.020 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2004 | 101 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2004 | 236 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2010 | 1485 | 0.010 |
Why?
|
| Maximum Tolerated Dose | 1 | 2005 | 892 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 2004 | 246 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2010 | 1546 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 2004 | 326 | 0.010 |
Why?
|
| Infant | 2 | 2015 | 35122 | 0.010 |
Why?
|
| Manganese | 1 | 2005 | 406 | 0.010 |
Why?
|
| Rare Diseases | 1 | 2007 | 552 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 2924 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2007 | 1048 | 0.010 |
Why?
|
| Fluorouracil | 1 | 2005 | 1619 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12354 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 2004 | 767 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 1143 | 0.010 |
Why?
|
| Stomach | 1 | 2004 | 697 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2005 | 2879 | 0.010 |
Why?
|
| Observer Variation | 1 | 2005 | 2592 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2004 | 2971 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2007 | 2241 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2012 | 7729 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2009 | 6441 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2003 | 4848 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2004 | 3510 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2004 | 4561 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 21733 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 18027 | 0.000 |
Why?
|
| Child | 1 | 2004 | 77637 | 0.000 |
Why?
|